Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2025/143444COMPOSITION COMPRISING CAMELLIA JAPONICA CALLUS-DERIVED EXOSOME AS ACTIVE INGREDIENT FOR IMPROVING SKIN CONDITION
WO 03.07.2025
Int.Class A61K 8/9789
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
8Cosmetics or similar toiletry preparations
18characterised by the composition
96containing materials, or derivatives thereof, of undetermined constitution
97from algae, fungi, lichens or plants; from derivatives thereof
9783Angiosperms
9789Magnoliopsida
Appl.No PCT/KR2024/014255 Applicant GFC LIFE SCIENCE CO., LTD. Inventor KANG, Hee Cheol
The present invention relates to a cosmetic composition comprising a camellia callus-derived exosome as an active ingredient for anti-inflammation, antioxidation, whitening, wrinkle reduction, moisturization, skin regeneration, skin barrier improvement, atopic dermatitis alleviation, and skin soothing. The Camellia callus-derived exosomes provided by the present invention have excellent effects as cosmetics for anti-inflammation, antioxidation, whitening, wrinkle reduction, moisturizing, skin barrier alleviation, atopic dermatitis alleviation, and skin soothing or as a pharmaceutical composition for anti-inflammation, atopic dermatitis alleviation, wound healing, and wound healing promotion.
2.WO/2025/139845USE OF TRADITIONAL CHINESE MEDICINE IN PREPARING DRUG FOR PREVENTING AND TREATING NEPHRITIS
WO 03.07.2025
Int.Class A61K 36/704
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
70Polygonaceae (Buckwheat family), e.g. spineflower or dock
704Polygonum, e.g. knotweed
Appl.No PCT/CN2024/139109 Applicant TSING HUA DE REN XI'AN XINGFU PHARMACEUTICAL CO. LTD. Inventor DU, Chengqiang
Use of a traditional Chinese medicine in preparing a drug for preventing and treating nephritis. The traditional Chinese medicine is prepared from Taraxacum officinale, Polygonum cuspidatum, Sonchus oleroceus L., and Herba Scutellariae barbatae. Danio rerio is adopted for modeling. Animal experiments prove that the traditional Chinese medicine can be used for treating nephritis caused by aristolochic acid, protecting kidney functions and/or ameliorating renal dysfunction edema, and specifically, promoting glomerular filtration.
3.WO/2025/140310COMPOSITION CONTAINING LYCIUM CHINENSE EXOSOMES, PREPARATION METHOD THEREFOR, AND USE THEREOF
WO 03.07.2025
Int.Class C12N 5/04
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
04Plant cells or tissues
Appl.No PCT/CN2024/142297 Applicant CELLULAR BIOPHARMA (SHANGHAI), LTD. Inventor LI, Ping
The present disclosure relates to a method for preparing Lycium chinense exosomes, Lycium chinense exosomes prepared via the method, and use thereof. Specifically, the preparation method for the Lycium chinense plant exosomes comprises a layer-by-layer filtration step, the layer-by-layer filtration step sequentially comprising depth filtration and any membrane filtration.
4.WO/2025/141615PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY CONDITIONS
WO 03.07.2025
Int.Class A61K 36/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
19Acanthaceae (Acanthus family)
Appl.No PCT/IN2024/052441 Applicant CIRA HERBALS LLP Inventor CHANDRAKUMAR SHAH, Gautam
The present invention provides a composition comprising extract of Nyctanthes arbortristis (NAT) and Andrographis paniculata (AP) for use in treating inflammatory conditions.
5.WO/2025/143175ALTERNATIVE AUTOPHAGY ACTIVATOR
WO 03.07.2025
Int.Class A23L 33/105
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
105Plant extracts, their artificial duplicates or their derivatives
Appl.No PCT/JP2024/046289 Applicant EZAKI GLICO CO., LTD. Inventor IKEHARA Ryohei
An alternative autophagy activator comprising at least one selected from the group consisting of: a coffee extract and/or a coffee residue extract; a black pepper extract; a red pine extract; a juniper berry extract; a turmeric extract; and an apple polyphenol extract.
6.WO/2025/140394USE OF MULBERRY EXTRACT IN PREPARING DRUG FOR TREATING AND/OR PREVENTING ABNORMAL BONE METABOLISM-RELATED DISEASES
WO 03.07.2025
Int.Class A61K 36/605
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
60Moraceae (Mulberry family), e.g. breadfruit or fig
605Morus (mulberry)
Appl.No PCT/CN2024/142684 Applicant BEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD Inventor LIU, Yuling
Provided is use of a mulberry extract in preparing a drug for treating and/or preventing abnormal bone metabolism-related diseases. The mulberry extract comprises, based on the sum of the weight percentages of components in the mulberry extract being 100%: 3-99% of alkaloid, 0.2-70% of polysaccharide, 0-10% of flavone, 0-50% of amino acid, and 0-25% of other components.
7.WO/2025/144085METHOD FOR TREATING PAIN
WO 03.07.2025
Int.Class A61K 36/25
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
Appl.No PCT/RU2024/050306 Applicant KOSMODEMIANSKII, Leonid Vladimirovich Inventor KOSMODEMIANSKII, Leonid Vladimirovich
The invention relates to medicine, and more particularly to algology, and can be used in the treatment of pain. The present method includes oral administration of a pharmaceutical composition. Administration begins with a minimum single dose comprising: 1 drop or granule of the composition, dissolved in 15 ml of water, per 10 kg of the patient’s weight. The minimum single dose is administered every 15 minutes. An individually tailored single dose is determined by adding up the minimum doses of the composition which induce a subjective sensation of a decrease in pain. The composition is administered in the individually tailored single dose at a dosage frequency of not more than 8 times a day on the first day and not more than four times a day on the second and subsequent days. The pharmaceutical composition contains equal quantities of Eupatorium perfoliatum in a 3D dilution, China officinalis, Secale comutum, Arnica montana in a 3C dilution, Rhus toxicodendron in a 4C dilution, Aconitum napellus, Belladonna, Bryonia alba, Ipecacuanha, Nux vomica in a 5C dilution, Mercurius solubilis in a 6C dilution, Abrotanum, Gallicum acidum, Heloderma suspectum, Senecio aureus in a 7C dilution, and Stramonium in a 9C dilution. The invention provides for a significant decrease in the pain sensations experienced by the patient, irrespective of the source of and reasons for the pain.
8.WO/2025/144685PET FOOD COMPOSITIONS AND METHODS OF USING THE SAME
WO 03.07.2025
Int.Class A23K 10/30
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
KFEEDING-STUFFS SPECIALLY ADAPTED FOR ANIMALS; METHODS SPECIALLY ADAPTED FOR PRODUCTION THEREOF
10Animal feeding-stuffs
30from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
Appl.No PCT/US2024/061110 Applicant HILL'S PET NUTRITION, INC. Inventor EPHRAIM, Eden
Described herein is a pet food composition comprising at least one fermentable fiber; betaine; carnitine; tryptophan; at least one fruit, vegetable, or extract thereof comprising phytochemicals; and at least two omega-3 polyunsaturated fatty acids. Also disclosed herein are methods of treating or preventing anxiety and/or an inflammation or allergy in a companion animal by administering the pet food composition to the companion animal.
9.WO/2025/143141AUTOPHAGY ACTIVATOR
WO 03.07.2025
Int.Class A23L 33/105
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
105Plant extracts, their artificial duplicates or their derivatives
Appl.No PCT/JP2024/046218 Applicant EZAKI GLICO CO., LTD. Inventor IKEHARA Ryohei
The present invention relates to an autophagy activator that contains an Alpinia zerumbet extract and/or a Dioscorea nipponica extract.
10.WO/2025/144221A FUNCTIONAL DIETARY SUPPLEMENT CONTAINING HAZELNUT EXTRACTS ENRICHED WITH HAZELNUT ANTICANCER COMPONENTS
WO 03.07.2025
Int.Class A61K 36/52
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
52Juglandaceae (Walnut family)
Appl.No PCT/TR2024/050814 Applicant MICRONUT BIYOTEKNOLOJI ANONIM SIRKETI Inventor ARI, Sule
The invention relates to a functional dietary supplement and contains at least one of the group of the kernel, shell, or cell powder of hazelnuts having anticancer, nutritive, and flavoring properties as active ingredients, and hazelnut anticancer components.